Global Pneumothorax Infection Treatment Market, By Type (Primary Spontaneous Pneumothorax, Secondary Spontaneous Pneumothorax, Latrogenic Pneumothorax, Injury-related Pneumothorax, Catamenial Pneumothorax), Treatment (Medication, Needle Aspiration, Chemical Pleurodesis, Chest Tube Drainage, Surgery, Others), Diagnosis (Chest X-ray, Computerized Tomography (CT) Scan, Ultrasound, Physical Examination, Others), Symptoms (Chest Pain, Tachypnoea, Dyspnoea, Dry cough, Subcutaneous emphysema, Signs of respiratory distress, Fatigue, Hypotension, Tachycardia, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Injectable, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.